SANARA MEDTECH INC. Contingent Consideration Classified as Equity, Fair Value Disclosure
SANARA MEDTECH INC. (SMTI) had Contingent Consideration Classified as Equity, Fair Value Disclosure of $584.24 thousand as of 2021-07-14, per its 10-K filed 2023-03-20.
Discontinued › Notes › Fair Value Disclosures
us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure · last filed 2023-03-20
- 2021-07-14: Contingent Consideration Classified as Equity, Fair Value Disclosure $584.24K.
| Period end | Contingent Consideration Classified as Equity, Fair Value Disclosure |
|---|---|
| 2021-07-14 | $584.24K 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B |